<DOC>
	<DOCNO>NCT02629224</DOCNO>
	<brief_summary>The objective study evaluate pharmacokinetics safety ASP8825 patient impair renal function haemodialysis .</brief_summary>
	<brief_title>ASP8825 - Pharmacokinetics Study Patients With Impaired Renal Function Haemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<criteria>Body weight : ≥40.0 kg &lt; 80.0 kg Body mass index BMI : ≥16.0 &lt; 30.0 [ BMI= Body weight ( kg ) / ( Height ( ) ) 2 ] For Renal impairment patient : Patients eGFR GFR predictive equation Japanese within &lt; 50 mL.min/1.73m2 screen undergoing dialysis For Haemodialysis patient : Patients receive dialysis screening Patients whose treatment regimen ( include diet ) renal impairment complication remain unchanged within 14 day prior dose , patient receive treatment ( include diet ) need change period 14 day dose followup examination opinion investigator subinvestigator . Female subject agree use effective contraception start informed consent throughout study period Patients complication history inappropriate study ( except complication primary disease renal dysfunction , like diabetes etc. , complication hypertension anemia etc . ) Patients complication history recur alimentary disease Patients history gastrointestinal surgical operation Patients complication severe heart disease Patients complication history malignant tumor ( However , patient without recurrence malignant tumor 5 year treatment may eligible study . ) Patients judge ineligible investigator subinvestigator base result medical examination , vital sign , 12ECG laboratory test Patients Hb value &lt; 9g/dL screening Patients receive scheduled receive study drug clinical trial postmarketing study within 120 day screen Patients receive scheduled receive medication within seven day dose investigational drug Patients previously receive administration Gabapentin ASP8825</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Impaired renal function</keyword>
	<keyword>Haemodialysis</keyword>
	<keyword>ASP8825</keyword>
	<keyword>XP13512</keyword>
</DOC>